Latest Articles
Biogen expands control of CD38 antibody felzartamab across global markets - Drug Discovery News
Biogen expands control of CD38 antibody felzartamab across global markets Drug Discovery News
Published: April 22, 2026, 9:23 p.m.
Link copied to clipboard!